Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

交易中 05-20 10:05:22 EDT

4.36

+0.03

+0.69%

最高4.48	最低4.30	成交量11.88万
今开4.41	昨收4.33	日振幅4.15%
总市值4.03亿	流通市值2.77亿	总股本9,241万
成交额52.45万	换手率0.19%	流通股本6,348万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":4.36,"timestamp":1716213919669,"preClose":4.33,"halted":0,"volume":118767,"delay":0,"floatShares":63478610,"shares":92412866,"eps":-1.373924,"marketStatus":"交易中","marketStatusCode":2,"change":0.03,"latestTime":"05-20 10:05:22 EDT","open":4.4089,"high":4.4799,"low":4.3,"amount":524522.4006495,"amplitude":0.041547,"askPrice":4.37,"askSize":200,"bidPrice":4.35,"bidSize":226,"shortable":3,"etf":0,"ttmEps":-1.373924,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716235200000},"adr":0,"listingDate":1595563200000,"adjPreClose":4.33,"preHourTrading":{"tag":"盘前","latestPrice":4.43,"preClose":4.33,"latestTime":"09:28 EDT","volume":594,"amount":2575.8598536,"timestamp":1716211715996},"postHourTrading":{"tag":"盘后","latestPrice":4.3896,"preClose":4.33,"latestTime":"18:47 EDT","volume":7358,"amount":31907.33,"timestamp":1715986041965},"volumeRatio":0.693774},"requestUrl":"/m/hq/s/ANNX/tweets","defaultTab":"tweets","newsList":[{"id":"2435888786","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435888786","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435888786?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报导的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435820688","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435820688","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435820688?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报道的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435151903","title":"Annexon, Inc.盘中异动 早盘快速拉升5.75%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435151903","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435151903?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:38","pubTimestamp":1715693914,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时38分，Annexon, Inc.股票出现波动，股价快速拉升5.75%。截至发稿，该股报5.15美元/股，成交量4.6148万股，换手率0.05%，振幅3.08%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142138347a59d8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142138347a59d8e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435437727","title":"BUZZ--美国股票走势-Annexon、MKS Instruments、Robinhood","url":"https://stock-news.laohu8.com/highlight/detail?id=2435437727","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435437727?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:09","pubTimestamp":1715616586,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      5月13日 - 美国股指周一走高，在近期连续上涨后接近纪录高位，投资者在等待本周的关键通胀数据，以判断2024年降息的可能性。美东时间 上午 11:58，道琼斯工业平均指数  下跌0.02%，报39,505.32点。标普500指数  上涨0.01%，报5,223.42点；纳斯达克综合指数  上涨0.26%，报16,383.04点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435736773","title":"Annexon, Inc.盘中异动 早盘股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435736773","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435736773?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:33","pubTimestamp":1715607216,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时33分，Annexon, Inc.股票出现异动，股价大幅拉升6.06%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Ac Immune Sa、Nutriband Inc C/Wts 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Reneo Pharmaceuticals, Inc.较为活跃，换手率分别为23.30%、15.65%、14.14%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa，振幅分别为26.92%、15.24%、14.72%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213337861eccc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213337861eccc9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434854045","title":"Annexon, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854045","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434854045?lang=zh_cn&edition=full","pubTime":"2024-05-10 01:40","pubTimestamp":1715276448,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日01时40分，Annexon, Inc.股票出现波动，股价大幅拉升5.13%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。公司的候选产品包括治疗自身免疫和神经退行性疾病的 ANX005，治疗眼科神经退行性疾病的 ANX007，口服小分子药物 ANX1502 以及治疗全身性自身免疫疾病的 ANX009。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100140487a590744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100140487a590744&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432908996","title":"Annexon, Inc.盘中异动 早盘股价大涨5.15%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908996","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432908996?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:31","pubTimestamp":1714743064,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时31分，Annexon, Inc.股票出现波动，股价大幅上涨5.15%。截至发稿，该股报4.90美元/股，成交量6.9241万股，换手率0.08%，振幅1.72%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213105861ead22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213105861ead22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432794699","title":"Annexon Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432794699","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432794699?lang=zh_cn&edition=full","pubTime":"2024-05-03 20:25","pubTimestamp":1714739116,"startTime":"0","endTime":"0","summary":"   * Annexon Inc    预计在5月6日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 Annexon Inc 每股亏损 34 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 8 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Annexon Inc 的 12 个月目标价中位数为 12.00 美元，高于其最新收盘价 4.66 美元。5月3日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432503606","title":"Annexon, Inc.盘中异动 早盘股价大涨5.05%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432503606","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432503606?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:52","pubTimestamp":1714571538,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时52分，Annexon, Inc.股票出现异动，股价快速拉升5.05%。截至发稿，该股报4.78美元/股，成交量5.4904万股，换手率0.06%，振幅3.96%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012152197a57dc17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012152197a57dc17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432837439","title":"Annexon, Inc.盘中异动 股价大跌5.32%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432837439","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432837439?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:01","pubTimestamp":1714492903,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日00时01分，Annexon, Inc.股票出现波动，股价急速下跌5.32%。截至发稿，该股报4.45美元/股，成交量93.169万股，换手率1.03%，振幅5.96%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501000144861ea779&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501000144861ea779&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430234346","title":"Annexon, Inc.盘中异动 急速上涨5.17%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430234346","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430234346?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:56","pubTimestamp":1714064161,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日00时56分，Annexon, Inc.股票出现波动，股价急速上涨5.17%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。消息层面，截至00时56分，《坎托菲茨杰拉德公司：重申Annexon增持评级。》资讯为影响Annexon, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426005601792382dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426005601792382dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429638424","title":"坎托菲茨杰拉德公司：重申Annexon(ANNX.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429638424","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429638424?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:05","pubTimestamp":1713963954,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Annexon(ANNX.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404242105578b4f034d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404242105578b4f034d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428658665","title":"Annexon, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428658665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428658665?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:04","pubTimestamp":1713539044,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时04分，Annexon, Inc.股票出现异动，股价大幅拉升5.18%。截至发稿，该股报4.67美元/股，成交量27.8426万股，换手率0.31%，振幅8.56%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923040487e822a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923040487e822a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427687825","title":"Annexon, Inc.盘中异动 股价大跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427687825","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427687825?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:56","pubTimestamp":1713275793,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时56分，Annexon, Inc.股票出现异动，股价快速下挫5.75%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621563487e80fc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621563487e80fc5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427998001","title":"Annexon, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427998001","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427998001?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:07","pubTimestamp":1713190063,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时07分，Annexon, Inc.股票出现波动，股价急速跳水5.02%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415220744861e5d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415220744861e5d1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426250515","title":"Annexon, Inc.盘中异动 早盘股价大涨5.02%报6.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426250515","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426250515?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:37","pubTimestamp":1712842643,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时37分，Annexon, Inc.股票出现异动，股价快速上涨5.02%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。该信息摘要如下：Needham：重申Annexon评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121372387e7fa32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121372387e7fa32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426253622","title":"Needham：重申Annexon(ANNX.US)评级，由买入调整至买入评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426253622","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426253622?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:25","pubTimestamp":1712834757,"startTime":"0","endTime":"0","summary":"Needham：重申Annexon(ANNX.US)评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119260087676660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119260087676660&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426445670","title":"Annexon, Inc.盘中异动 下午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426445670","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426445670?lang=zh_cn&edition=full","pubTime":"2024-04-11 01:40","pubTimestamp":1712770801,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日01时40分，Annexon, Inc.股票出现异动，股价快速下挫5.14%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411014002791fb160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411014002791fb160&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425291510","title":"Annexon, Inc.盘中异动 大幅下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425291510","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425291510?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:58","pubTimestamp":1712584726,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时58分，Annexon, Inc.股票出现异动，股价急速下挫5.56%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Annexon, Inc.公司简介：Annexon Inc是一家临床生物制药公司，致力于为患有经典补体介导的身体，大脑和眼睛疾病的患者开发一系列新疗法。Annexon的候选产品是ANX005，用于自身免疫和神经退行性疾病；ANX007，用于神经退行性眼科疾病；以及ANX009，用于系统性自身免疫疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408215846861e3f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408215846861e3f05&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com","stockEarnings":[{"period":"1week","weight":-0.0884},{"period":"1month","weight":-0.0556},{"period":"3month","weight":-0.1559},{"period":"6month","weight":0.6654},{"period":"1year","weight":-0.2534},{"period":"ytd","weight":-0.0463}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.043018},{"month":2,"riseRate":0.5,"avgChangeRate":0.014392},{"month":3,"riseRate":0.25,"avgChangeRate":-0.117935},{"month":4,"riseRate":0.25,"avgChangeRate":-0.084387},{"month":5,"riseRate":0.5,"avgChangeRate":-0.048413},{"month":6,"riseRate":1,"avgChangeRate":0.147903},{"month":7,"riseRate":0.333333,"avgChangeRate":0.081537},{"month":8,"riseRate":0.5,"avgChangeRate":0.025093},{"month":9,"riseRate":0.75,"avgChangeRate":0.068201},{"month":10,"riseRate":0,"avgChangeRate":-0.174969},{"month":11,"riseRate":0.75,"avgChangeRate":0.099167},{"month":12,"riseRate":0.5,"avgChangeRate":0.128325}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况